No Data
No Data
Organic chemicals, Sanshin Electric, Tokyu Construction, etc.
<4531> Organic drugs continued to increase drastically by 310 +18. Revisions to earnings forecasts were announced the day before. Operating income for the fiscal year ended March 24 was revised upward from the previous forecast of 840 million yen to 1.11 billion yen, an increase of 23.7% from the previous fiscal year. Since there was a 2-digit decline in operating profit until the 3rd quarter, it seems that the positive impact is intensifying. The effects of the depreciation of the yen, contributions of new products for electronic materials, expansion of sales of raw materials developed overseas, and cost reduction effects seem to be in the background. The annual dividend is also the conventional plan
Sanshin Electric --- drastic increase, review movement progresses in response to upward revisions to earnings forecasts
Significant continued growth. Revisions to earnings forecasts were announced the day before. Operating profit was revised upward from the previous forecast of 4.4 billion yen to 5.7 billion yen, down 16.8% from the previous fiscal year. It seems that performance gains were not factored in from current stock price trends. As the performance of the solution business with high profit margins remained strong, it seems that profits expanded even as sales declined. Also, the annual dividend has been raised from the previous plan of 100 yen to 105 yen.
No Data